Marc Tessier-Lavigne Insider Trading $JUNO Juno Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Marc Tessier-Lavigne.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Marc Tessier-Lavigne. Marc Tessier-Lavigne is EVP, RESEARCH DRUG DISCOVERY in GENENTECH INC ($DNA) and Director in PFIZER INC ($PFE) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Denali Therapeutics Inc. ($DNLI).

Marc Tessier-Lavigne in Juno Therapeutics, Inc.

Trading Symbol: JUNO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2016
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Marc Tessier-Lavigne in Juno Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGIO, DNLI, DNA, JUNO, PFE, REGN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 21 2016JUNOJuno Therapeutics, ...Tessier-Lavigne MarcDirectorOption ExerciseA42.4012,000508,80012,000
Jun 16 2015JUNOJuno Therapeutics, ...Tessier-Lavigne MarcDirectorOption ExerciseA60.0012,000720,00012,000

Page:   1